Clinical Trial Update: A Single Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers [Phase 1]

View source ↗

Summary

This document reports a Phase 1 single-dose tolerability and pharmacokinetic study in overweight or obese volunteers with Type 2 diabetes mellitus. The sponsor …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Genaera Corporation | Conditions: Diabetes Mellitus, Obesity | Phase 1 | Status: COMPLETED